Impact of comorbid borderline personality disorder on the outcome of inpatient treatment for anorexia nervosa: a retrospective chart review.

Anorexia nervosa Borderline personality disorder Eating disorder Inpatient treatment Multilevel modeling Routine care

Journal

Borderline personality disorder and emotion dysregulation
ISSN: 2051-6673
Titre abrégé: Borderline Personal Disord Emot Dysregul
Pays: England
ID NLM: 101650634

Informations de publication

Date de publication:
11 Mar 2021
Historique:
received: 23 03 2020
accepted: 15 02 2021
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 12 3 2021
Statut: epublish

Résumé

Data on patients with anorexia nervosa (AN) and comorbid Borderline personality disorder (AN+BPD) are scarce. Therefore, we investigated (1) whether patients with AN and AN+BPD differ in characteristics related to admission to, discharge from, and course of specialized inpatient eating disorder treatment and (2) how comorbid BPD affects treatment outcome. One-thousand one-hundred and sixty inpatients with AN (97.2% female, 5.9% with comorbid BPD; mean age = 26.15, SD = 9.41) were administered the Brief Symptom Inventory (BSI), the Eating Disorder Inventory 2 (EDI-2), and the Global Assessment of Functioning (GAF) at admission and discharge. Data were extracted by a retrospective chart review of naturalistic treatment data. Age, sex, weekly weight gain, length of stay, and discharge characteristics were compared with independent t-tests and χ No differences in age or sex were found between patients with AN and AN+BPD, but groups differed in previous inpatient treatments, BMI at admission, and frequency of at least one additional comorbidity with higher values for AN+BPD. Higher levels of disorder-specific and general psychopathology at admission were found for AN+BPD. Patients with AN showed statistically significant improvement in all examined variables, patients with AN+BPD improved in all variables except EDI-2 body dissatisfaction. Strongest improvements in patients with AN+BPD occurred in BMI (Cohen's d = 1.08), EDI-2 total score (Cohen's d = 0.99), EDI-2 interpersonal distrust (d = 0.84). Significant Group x Time Interactions were observed for BSI GSI, GAF, and EDI-2 body dissatisfaction, indicating a reduced benefit from inpatient treatment in AN+BPD. At discharge, no differences were found in weekly weight gain, BMI, length of stay, or discharge characteristics (e.g., ability to work, reason for discharge), however, patients with AN+BPD were more frequently treated with medication. Patients with AN+BPD differ from patients with AN in that they show higher general and specific eating disorder psychopathology and only partially improve under specialized inpatient treatment. In particular, aspects of emotion regulation and core AN symptoms like body dissatisfaction and perfectionism need to be even more targeted in comorbid patients.

Sections du résumé

BACKGROUND BACKGROUND
Data on patients with anorexia nervosa (AN) and comorbid Borderline personality disorder (AN+BPD) are scarce. Therefore, we investigated (1) whether patients with AN and AN+BPD differ in characteristics related to admission to, discharge from, and course of specialized inpatient eating disorder treatment and (2) how comorbid BPD affects treatment outcome.
METHOD METHODS
One-thousand one-hundred and sixty inpatients with AN (97.2% female, 5.9% with comorbid BPD; mean age = 26.15, SD = 9.41) were administered the Brief Symptom Inventory (BSI), the Eating Disorder Inventory 2 (EDI-2), and the Global Assessment of Functioning (GAF) at admission and discharge. Data were extracted by a retrospective chart review of naturalistic treatment data. Age, sex, weekly weight gain, length of stay, and discharge characteristics were compared with independent t-tests and χ
RESULTS RESULTS
No differences in age or sex were found between patients with AN and AN+BPD, but groups differed in previous inpatient treatments, BMI at admission, and frequency of at least one additional comorbidity with higher values for AN+BPD. Higher levels of disorder-specific and general psychopathology at admission were found for AN+BPD. Patients with AN showed statistically significant improvement in all examined variables, patients with AN+BPD improved in all variables except EDI-2 body dissatisfaction. Strongest improvements in patients with AN+BPD occurred in BMI (Cohen's d = 1.08), EDI-2 total score (Cohen's d = 0.99), EDI-2 interpersonal distrust (d = 0.84). Significant Group x Time Interactions were observed for BSI GSI, GAF, and EDI-2 body dissatisfaction, indicating a reduced benefit from inpatient treatment in AN+BPD. At discharge, no differences were found in weekly weight gain, BMI, length of stay, or discharge characteristics (e.g., ability to work, reason for discharge), however, patients with AN+BPD were more frequently treated with medication.
CONCLUSIONS CONCLUSIONS
Patients with AN+BPD differ from patients with AN in that they show higher general and specific eating disorder psychopathology and only partially improve under specialized inpatient treatment. In particular, aspects of emotion regulation and core AN symptoms like body dissatisfaction and perfectionism need to be even more targeted in comorbid patients.

Identifiants

pubmed: 33691782
doi: 10.1186/s40479-021-00149-7
pii: 10.1186/s40479-021-00149-7
pmc: PMC7948359
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8

Références

World Psychiatry. 2012 Oct;11(3):181-5
pubmed: 23024678
J Behav Ther Exp Psychiatry. 2010 Dec;41(4):381-8
pubmed: 20444442
Int J Methods Psychiatr Res. 2009 Sep;18(3):169-84
pubmed: 19701924
Eur Eat Disord Rev. 2007 Nov;15(6):430-8
pubmed: 17726661
Int J Eat Disord. 1994 Apr;15(3):233-43
pubmed: 8199603
Int J Eat Disord. 2015 Nov;48(7):946-71
pubmed: 26171853
Psychother Psychosom Med Psychol. 2017 Sep;67(9-10):420-430
pubmed: 28511240
Borderline Personal Disord Emot Dysregul. 2016 Jun 01;3:3
pubmed: 27252857
Eat Disord. 2019 Jul 15;:1-14
pubmed: 31305226
Borderline Personal Disord Emot Dysregul. 2019 Jan 16;6:1
pubmed: 30680217
Int J Eat Disord. 2010 Apr;43(3):226-32
pubmed: 19343799
Psychiatr Clin North Am. 1996 Dec;19(4):843-59
pubmed: 9045226
J Nerv Ment Dis. 2012 Sep;200(9):807-13
pubmed: 22922238
Eur Eat Disord Rev. 2017 Jan;25(1):3-12
pubmed: 27862611
J Clin Psychol. 2020 Apr;76(4):787-800
pubmed: 31953849
Psychiatry Res. 2009 Dec 30;170(2-3):252-5
pubmed: 19896721
Psychol Med. 2001 Jul;31(5):881-90
pubmed: 11459385
BMC Psychiatry. 2014 Sep 06;14:258
pubmed: 25193513
Eur Eat Disord Rev. 2016 May;24(3):214-22
pubmed: 26603278
J Psychosom Res. 1998 May;44(5):565-71
pubmed: 9623877
Psychosom Med. 2011 Nov-Dec;73(9):769-74
pubmed: 22042882
Trials. 2016 Nov 17;17(1):549
pubmed: 27855714
J Eat Disord. 2015 Oct 01;3:34
pubmed: 26435836
Am J Psychiatry. 1999 Oct;156(10):1570-4
pubmed: 10518168
Eat Weight Disord. 2017 Jun;22(2):201-209
pubmed: 27995489

Auteurs

Ulrich Voderholzer (U)

Schoen Clinic Roseneck, Prien am Chiemsee, Am Roseneck 6, D-83209, Prien am Chiemsee, Germany.
Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, Freiburg, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Matthias Favreau (M)

Schoen Clinic Roseneck, Prien am Chiemsee, Am Roseneck 6, D-83209, Prien am Chiemsee, Germany.

Sandra Schlegl (S)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Johannes Baltasar Hessler-Kaufmann (JB)

Schoen Clinic Roseneck, Prien am Chiemsee, Am Roseneck 6, D-83209, Prien am Chiemsee, Germany. johannes.hessler@med.uni-muenchen.de.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany. johannes.hessler@med.uni-muenchen.de.

Classifications MeSH